BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11486987)

  • 1. An organizational tool to describe and evaluate group performance in the health care setting.
    Nair KV; Ascione FJ; Bagozzi RP; Mannebach MA
    J Am Pharm Assoc (Wash); 2001; 41(4):608-17. PubMed ID: 11486987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence prescribing decisions.
    Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
    Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-role relationships in hospital-based pharmacy and therapeutics committee decision making.
    Bagozzi RP; Ascione FJ; Mannebach MA
    J Health Psychol; 2005 Jan; 10(1):45-64. PubMed ID: 15576500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing.
    Schönenberger N; Meyer-Massetti C; Bravo S
    Eur J Hosp Pharm; 2024 Feb; 31(2):171-174. PubMed ID: 36241377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of a pharmacy department in a hospital's transition to patient-centered care.
    Mansur JM; Chamerlik SJ; Bohenek W; Leonard TM; Dean RP
    Top Hosp Pharm Manage; 1994 Apr; 14(1):36-45. PubMed ID: 10133558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
    Weekes LM; Day RO
    Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals.
    Mashaba TP; Matlala M; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):159-168. PubMed ID: 30407089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of stakeholder involvement in hospital policy decision-making: a study of the hospital's business processes.
    Malfait S; Van Hecke A; Hellings J; De Bodt G; Eeckloo K
    Acta Clin Belg; 2017 Feb; 72(1):63-71. PubMed ID: 27762170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How organizational context affects bioethical decision-making: pharmacists' management of gatekeeping processes in retail and hospital settings.
    Chiarello E
    Soc Sci Med; 2013 Dec; 98():319-29. PubMed ID: 23337832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of pharmacoeconomic data in making hospital formulary decisions.
    Odedina FT; Sullivan J; Nash R; Clemmons CD
    Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritising drug and therapeutics committee (DTC) decisions: a national survey.
    Tan EL; Day RO; Brien JA
    Pharm World Sci; 2007 Apr; 29(2):90-6. PubMed ID: 17187221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
    Pedersen CA; Schneider PJ; Santell JP
    Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.
    Chen LC; Ashcroft DM; Elliott RA
    Pharm World Sci; 2007 Dec; 29(6):661-70. PubMed ID: 17566869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals.
    Puigventós F; Santos-Ramos B; Ortega A; Durán-García E
    Pharm World Sci; 2010 Dec; 32(6):767-75. PubMed ID: 20820918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.